biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Feb 22, 2017 8:29pm

197 Views

Post# 25880514

RE:RE:RE:hey jekyl...just a question? ??

Have a look at the deal funnel in the Tailwinds report.

1. How many licenses are pending?
2. How many evaluations are underway?
3. How many evaluations are pending?
4. What does it say the timeline is for an evaluation and conversion to a liscence?

How many licenses could we see this year based upon the above?

Hey clown, what does it matter?

Given what you said a week ago....

NASDAQ Biotech Index up ~10% this year and BTI is in a world of hurt.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!